製品: Phospho-GRK2 (Ser670) Antibody
カタログ: AF3697
タンパク質の説明: Rabbit polyclonal antibody to Phospho-GRK2 (Ser670)
アプリケーション: WB IF/ICC
反応性: Human, Mouse, Rat
分子量: 80kD(Calculated).
ユニプロット: P25098
RRID: AB_2847011

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $350 在庫あり
 200ul $450 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
アプリケーション:
IF/ICC 1:100-1:500, WB 1:500-1:2000
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
クローナリティ:
Polyclonal
特異性:
Phospho-GRK2 (Ser670) Antibody detects endogenous levels of GRK2 only when phosphorylated at Ser670.
RRID:
AB_2847011
引用形式: Affinity Biosciences Cat# AF3697, RRID:AB_2847011.
コンジュゲート:
Unconjugated.
精製:
The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

ADRBK1; Adrenergic beta receptor kinase 1; ARBK1_HUMAN; BARK; BARK1; Beta adrenergic receptor kinase 1; Beta ARK 1; Beta ARK1; Beta-adrenergic receptor kinase 1; Beta-ARK-1; FLJ16718; G protein coupled receptor kinase 2; G-protein coupled receptor kinase 2; GRK2;

免疫原

免疫原:

A synthesized peptide derived from human GRK2 around the phosphorylation site of Ser670.

Uniprot:
遺伝子(ID):
発現特異性:
P25098 ARBK1_HUMAN:

Expressed in peripheral blood leukocytes.

タンパク質配列:
MADLEAVLADVSYLMAMEKSKATPAARASKKILLPEPSIRSVMQKYLEDRGEVTFEKIFSQKLGYLLFRDFCLNHLEEARPLVEFYEEIKKYEKLETEEERVARSREIFDSYIMKELLACSHPFSKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEARKKAKNKQLGHEEDYALGKDCIMHGYMSKMGNPFLTQWQRRYFYLFPNRLEWRGEGEAPQSLLTMEEIQSVEETQIKERKCLLLKIRGGKQFILQCDSDPELVQWKKELRDAYREAQQLVQRVPKMKNKPRSPVVELSKVPLVQRGSANGL

PTMs - P25098 基板として

Site PTM Type Enzyme
Y13 Phosphorylation P00533 (EGFR) , P12931 (SRC)
S29 Phosphorylation P17252 (PRKCA) , P05129 (PRKCG) , Q05655 (PRKCD)
K31 Ubiquitination
K45 Ubiquitination
R50 Methylation
T54 Phosphorylation
K57 Ubiquitination
K62 Ubiquitination
Y86 Phosphorylation P00533 (EGFR) , P12931 (SRC)
Y92 Phosphorylation P12931 (SRC) , P00533 (EGFR)
K94 Ubiquitination
K115 Ubiquitination
K126 Ubiquitination
K138 Ubiquitination
K139 Ubiquitination
K164 Ubiquitination
K170 Ubiquitination
Y206 Phosphorylation
T213 Phosphorylation
K215 Ubiquitination
K220 Ubiquitination
K230 Ubiquitination
S247 Phosphorylation
T248 Phosphorylation
T263 Phosphorylation
K319 Ubiquitination
K344 Ubiquitination
K345 Ubiquitination
K346 Ubiquitination
S350 Phosphorylation
T353 Phosphorylation
Y356 Phosphorylation
S416 Phosphorylation
S423 Phosphorylation
K448 Ubiquitination
S487 Phosphorylation
K494 Ubiquitination
K497 Ubiquitination
S501 Phosphorylation
Y506 Phosphorylation
K545 Ubiquitination
K557 Ubiquitination
K628 Ubiquitination
K644 Acetylation
K644 Ubiquitination
S670 Phosphorylation P27361 (MAPK3) , P24941 (CDK2)
S676 Phosphorylation
K677 Ubiquitination
R683 Methylation
S685 Phosphorylation P17612 (PRKACA)

PTMs - P25098 酵素として

Substrate Site Source
P05387 (RPLP2) S102 Uniprot
P05387 (RPLP2) S105 Uniprot
P07550 (ADRB2) S355 Uniprot
P07550 (ADRB2) S356 Uniprot
P07550 (ADRB2) T384 Uniprot
P07550 (ADRB2) S396 Uniprot
P07550 (ADRB2) S401 Uniprot
P07550 (ADRB2) S407 Uniprot
P07550 (ADRB2) S411 Uniprot
P08069 (IGF1R) S1278 Uniprot
P08172 (CHRM2) S232 Uniprot
P08172 (CHRM2) S234 Uniprot
P08172 (CHRM2) S250 Uniprot
P08172 (CHRM2) S251 Uniprot
P08172 (CHRM2) T271 Uniprot
P08172 (CHRM2) S282 Uniprot
P08172 (CHRM2) S283 Uniprot
P08172 (CHRM2) S286 Uniprot
P08172 (CHRM2) T287 Uniprot
P08172 (CHRM2) S288 Uniprot
P08172 (CHRM2) S290 Uniprot
P08172 (CHRM2) S294 Uniprot
P08172 (CHRM2) T302 Uniprot
P08172 (CHRM2) T307 Uniprot
P08172 (CHRM2) S309 Uniprot
P08172 (CHRM2) T310 Uniprot
P08172 (CHRM2) S311 Uniprot
P09497 (CLTB) S205 Uniprot
P15311 (EZR) T567 Uniprot
P18545 (PDE6G) T62 Uniprot
P21731-2 (TBXA2R) S239 Uniprot
P21731-2 (TBXA2R) S357 Uniprot
P26038 (MSN) T558 Uniprot
P30411 (BDKRB2) S366 Uniprot
P30411 (BDKRB2) S373 Uniprot
P30411 (BDKRB2) S375 Uniprot
P32245 (MC4R) T312 Uniprot
P32245 (MC4R) S329 Uniprot
P32245 (MC4R) S330 Uniprot
P35241 (RDX) T564 Uniprot
P35367 (HRH1) S398 Uniprot
P35372 (OPRM1) T356 Uniprot
P35372 (OPRM1) S357 Uniprot
P35372 (OPRM1) S358 Uniprot
P35372 (OPRM1) S377 Uniprot
P37840 (SNCA) S129 Uniprot
P41143 (OPRD1) T358 Uniprot
P41143 (OPRD1) S363 Uniprot
Q14940 (SLC9A5) S702 Uniprot
Q14940 (SLC9A5) S709 Uniprot
Q14940 (SLC9A5) S711 Uniprot
Q14940 (SLC9A5) S712 Uniprot
Q14940 (SLC9A5) T714 Uniprot
Q15796 (SMAD2) T197 Uniprot
Q16539 (MAPK14) T123 Uniprot
Q96A54 (ADIPOR1) S7 Uniprot
Q96A54 (ADIPOR1) T24 Uniprot
Q96A54 (ADIPOR1) T53 Uniprot
Q9Y2W7 (KCNIP3) S95 Uniprot

研究背景

機能:

Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors, probably inducing a desensitization of them. Key regulator of LPAR1 signaling. Competes with RALA for binding to LPAR1 thus affecting the signaling properties of the receptor. Desensitizes LPAR1 and LPAR2 in a phosphorylation-independent manner. Positively regulates ciliary smoothened (SMO)-dependent Hedgehog (Hh) signaling pathway by facilitating the trafficking of SMO into the cilium and the stimulation of SMO activity (By similarity).

細胞の位置付け:

Cytoplasm. Cell membrane.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
組織特異性:

Expressed in peripheral blood leukocytes.

サブユニット構造:

Interacts with GIT1 (By similarity). Interacts with, and phosphorylates chemokine-stimulated CCR5. Interacts with ARRB1. Interacts with LPAR1 and LPAR2. Interacts with RALA in response to LPAR1 activation. ADRBK1 and RALA mutually inhibit each other's binding to LPAR1. Interacts with ADRB2.

タンパク質ファミリー:

The PH domain binds anionic phospholipids and helps recruiting ADRBK1 from the cytoplasm to plasma membrane close to activated receptors. It mediates binding to G protein beta and gamma subunits, competing with G-alpha subunits and other G-betagamma effectors.

Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. GPRK subfamily.

研究領域

· Cellular Processes > Transport and catabolism > Endocytosis.   (View pathway)

· Environmental Information Processing > Signal transduction > Hedgehog signaling pathway.   (View pathway)

· Human Diseases > Substance dependence > Morphine addiction.

· Organismal Systems > Immune system > Chemokine signaling pathway.   (View pathway)

· Organismal Systems > Nervous system > Glutamatergic synapse.

· Organismal Systems > Sensory system > Olfactory transduction.

参考文献

1). Low-dose ethanol consumption inhibits neutrophil extracellular traps formation to alleviate rheumatoid arthritis. Communications biology, 2023 (PubMed: 37884797) [IF=5.9]

Application: WB    Species: Human    Sample: dHL-60 cells

Fig. 6 Acetate reduces ERS in neutrophils and inhibits the formation of NETs. a Scanning electron microscopy observation of treated neutrophils (Scale Bar: 2 μm). i: Neutrophil-like differentiation of HL-60 (dHL-60) cells that developed NETs after 4 h of PMA treatment in vitro. ii: There were no NETs in dHL-60 cells treated with acetate and PMA. b Immunofluorescence staining of Sytox-green (green) and MPO (red) in dHL-60 cells, showing that NETs are reduced under sodium acetate treatment (Scale Bar: 50 μm and 25 μm). c Immunofluorescence staining of MPO (green) and p-IRE1 (red) in dHL-60 cells, showing that MPO and p-IRE1 co-localization is reduced under sodium acetate treatment (Scale Bar: 10 μm and 50 μm). d The effects of GRP78/p-IRE1/IRE1/CHOP/ATF6/XBP1/H3cit/MPO in dHL-60 cells exposed to different concentrations of acetate. Data are representative of three independent experiments. e The effects of H3cit/MPO in dHL-60 cells exposed to different concentrations of ethanol. Data are representative of three independent experiments. f The effects of acetate receptor GPR43 and its downstream proteins in dHL-60 cells after stimulated by TG. Data are representative of three independent experiments. g The effects of GRP78/p-IRE1/IRE1/CHOP/ATF6/XBP1/H3cit/MPO in dHL-60 cells after stimulated by TG. Data are representative of three independent experiments. h Immunoprecipitation analysis of ubiquitination of endogenous GRK2 in dHL-60 cells. Data are representative of three independent experiments.

2). The ROS/GRK2/HIF-1α/NLRP3 Pathway Mediates Pyroptosis of Fibroblast-Like Synoviocytes and the Regulation of Monomer Derivatives of Paeoniflorin. Oxidative Medicine and Cellular Longevity, 2022 (PubMed: 35132350)

Application: WB    Species: Human    Sample:

Figure 6 Monomeric derivative of paeoniflorin (MDP) inhibits the expression of hypoxia-inducible factor (HIF)-1α through targeted inhibition of GRK2 S670 phosphorylation. (a) Molecular docking modeling of the compound MDP and G protein-coupled receptor kinase 2 (GRK2), the small molecule, and the critical interaction of 3KRW (human GRK2 in complex with Gbetgamma subunits and balanol) are represented by sticks. (b) A schematic representation of the binding mode of MDP in the GRK2 binding site of 3KRW. (c, d) FLS were treated with or without MDP and exposed to hypoxia for 2 h. Immunoblot analysis and quantification of GRK2, p-GRK2 (S670), and HIF-1α. The values are shown as the mean ± standard error of the mean (n = 3). ∗p < 0.05 compared with the control group and #p < 0.05 compared with the hypoxia group.

3). Alcohol Consumption Alleviates Rheumatoid Arthritis by Promoting Acetate Production and Inhibiting NETs Formation. , 2023

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.